We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · April 27, 2022

Efficacy and Safety of TNF-α Antagonists and Tocilizumab in Takayasu Arteritis

Rheumatology (Oxford, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Rheumatology (Oxford, England)
Efficacy and Safety of TNF-α Antagonists and Tocilizumab in Takayasu Arteritis: Multicentre Retrospective Study of 209 Patients
Rheumatology (Oxford) 2022 Apr 11;61(4)1376-1384, A Mekinian, L Biard, L Dagna, P Novikov, C Salvarani, O Espitia, S Sciascia, M Michaud, M Lambert, J Hernández-Rodríguez, N Schleinitz, A Awisat, X Puéchal, A Aouba, H Munoz Pons, I Smitienko, JB Gaultier, E Le Mouel, Y Benhamou, A Perlat, P Jego, T Goulenok, K Sacre, B Lioger, N Hassold, J Broner, V Dufrost, T Sene, J Seguier, F Maurier, S Berthier, A Belot, F Frikha, G Denis, A Audemard-Verger, I Kone Pault, S Humbert, P Woaye-Hune, A Tomelleri, E Baldissera, M Kuwana, A Lo Gullo, F Gaches, P Zeminsky, E Galli, M Alvarado, L Boiardi, F Muratore, M Vautier, C Campochiaro, S Moiseev, P Cacoub, O Fain, D Saadoun

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading